-
公开(公告)号:US20250162931A1
公开(公告)日:2025-05-22
申请号:US18839856
申请日:2023-01-31
Applicant: NIPPON ELECTRIC GLASS CO., LTD.
Inventor: Toru SHIRAGAMI , Satoshi ARAI
IPC: C03C17/30 , C03C17/00 , C09D183/04
Abstract: A coating agent for forming a coating layer on a glass surface or a resin surface includes an organopolysiloxane compound having organic substituents which are a methyl group and a phenyl group, and an organic substituent which is an acrylic group and/or a vinyl group.
-
公开(公告)号:US20240018033A1
公开(公告)日:2024-01-18
申请号:US18374248
申请日:2023-09-28
Applicant: Nippon Electric Glass Co., Ltd.
Inventor: Satoshi ARAI
Abstract: The present invention relates to a glass for a pharmaceutical container that is excellent in ultraviolet shielding ability, and is also excellent in chemical durability. The glass for a pharmaceutical container of the present invention includes as a glass composition, in terms of mass %, 67% to 81% of SiO2, more than 4% to 7% of Al2O3, 7% to 14% of B2O3, 3% to 12% of Na2O+K2O, 0% to 1.8% of CaO+BaO, 0.5% to less than 2% of Fe2O3, and 1% to 5% of TiO2, and satisfies a relationship of CaO/BaO≤0.5.
-
公开(公告)号:US20200283331A1
公开(公告)日:2020-09-10
申请号:US16648878
申请日:2018-10-16
Applicant: Nippon Electric Glass Co., Ltd.
Inventor: Satoshi ARAI
Abstract: The present invention relates to a glass for a pharmaceutical container that is excellent in ultraviolet shielding ability, and is also excellent in chemical durability. The glass for a pharmaceutical container of the present invention includes as a glass composition, in terms of mass %, 67% to 81% of SiO2, more than 4% to 7% of Al2O3, 7% to 14% of B2O3, 3% to 12% of Na2O+K2O, 0% to 1.8% of CaO+BaO, 0.5% to less than 2% of Fe2O3, and 1% to 5% of TiO2, and satisfies a relationship of CaO/BaO≤0.5.
-
4.
公开(公告)号:US20230167007A1
公开(公告)日:2023-06-01
申请号:US17912072
申请日:2021-04-13
Applicant: NIPPON ELECTRIC GLASS CO., LTD.
Inventor: Satoshi ARAI
CPC classification number: C03C3/091 , C03C4/20 , C03C2201/32
Abstract: A glass for a pharmaceutical container of the present invention contains, as a glass composition, in terms of mol %, 70% to 85% of SiO2, 3% to 13% of Al2O3, 0% to 5% of B2O3, 0.1% to 18% of Li2O+Na2O+K2O, and 0% to 10% of MgO+CaO+SrO+BaO, in which a molar ratio (Li2O+Na2O+K2O)/Al2O3 is 1 or more and a molar ratio (Li2O+Na2O+K2O+MgO+CaO+SrO+BaO—Al2O3)/(SiO2+Al2O3) is 0.2 or less.
-
公开(公告)号:US20230123424A1
公开(公告)日:2023-04-20
申请号:US18071129
申请日:2022-11-29
Applicant: Nippon Electric Glass Co., Ltd.
Inventor: Satoshi ARAI
Abstract: The present invention relates to a glass for a pharmaceutical container that is excellent in ultraviolet shielding ability, and is also excellent in chemical durability. The glass for a pharmaceutical container of the present invention includes as a glass composition, in terms of mass %, 67% to 81% of SiO2, more than 4% to 7% of Al2O3, 7% to 14% of B2O3, 3% to 12% of Na2O+K2O, 0% to 1.8% of CaO+BaO, 0.5% to less than 2% of Fe2O3, and 1% to 5% of TiO2, and satisfies a relationship of CaO/BaO≤0.5.
-
6.
公开(公告)号:US20210371324A1
公开(公告)日:2021-12-02
申请号:US17294140
申请日:2019-12-24
Applicant: Nippon Electric Glass Co., Ltd.
Inventor: Satoshi ARAI , Masato KAKUMA
Abstract: The present invention provides a glass for a pharmaceutical container, which includes as a glass composition, in terms of mol %, 69% to 81% of SiO2, 4% to 12% of Al2O3, 0% to 5% of B2O3, 5% to 20% of Li2O+Na2O+K2O, 0% to 12% of Li2O, 0% to 11% of Na2O, 0.01% to 11% of MgO+CaO+SrO+BaO, and 0.01% to 11% of CaO, which satisfies the following relationship: a molar ratio MgO/CaO
-
-
-
-
-